Philippines Pharmaceuticals & Healthcare Report Q4 2014 - New Report Available
The Philippine government's aim to lower pharmaceutical expenditure through medicine price cuts, parallel imports and the use of generic drugs will continue to hinder multinational pharmaceutical firms' investment and interest in the country's pharmaceutical market. Nevertheless, the government's intention to improve healthcare through the implementation of a universal healthcare scheme will continue to present significant revenue-generating opportunities for firms over the long term.
View full press release